First Citizens Bank & Trust’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

First Citizens Bank & Trust’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,466	Closed	-$436K	–	407
2022 Q2	$436K	Sell	5,466 -485	-8%	-$45.9K	0.02%	234
2022 Q1	$626K	Sell	5,951 -574	-9%	-$55.9K	0.02%	209
2021 Q4	$704K	Buy	6,525 +349	+6%	+$38.1K	0.03%	199
2021 Q3	$677K	Buy	+6,176	New	+$641K	0.03%	196

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

First Citizens Bank & Trust's HZNP Position: Q3 2022 in Review

First Citizens Bank & Trust sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 5,466 shares — an estimated $436K sold.

First Citizens Bank & Trust first reported a position in HZNP in Q3 2021 and held it in 4 quarters. The position peaked at $704K in Q4 2021. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

First Citizens Bank & Trust reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
First Citizens Bank & Trust sold 5,466 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $436K.
First Citizens Bank & Trust first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2021 and held it in 4 quarters.
First Citizens Bank & Trust's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $704K in Q4 2021.
530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on First Citizens Bank & Trust's 13F filing for Q3 2022, filed 20 Oct 2022.